Manitoba C. Difficile Prevention Proposal
PARTNER WITH US
CDI infections cost Manitoba healthcare millions, endanger seniors, and fuel antibiotic resistance—while infecting the Indigenous population at twice the rate. Manitoba can lead the world in stopping CDI, with a safe, natural solution developed locally by Manitoba scientists, produced by our farmers, and proven 94% effective at curing active infections.
The Problem: CDI is Costly & Deadly in MB Hospitals
-
Seniors (65+) entering MB hospitals face high CDI risk, with ~10% mortality.
-
Treatment costs per CDI case exceed $20,000 (antibiotics, extended stays, isolation).
-
AMR (antimicrobial resistance) is worsened by repeated antibiotic use for CDI.
Our Solution: IgY Antibody Prevention
-
Proven Science: Same antibodies used in our Phase 2 therapeutic trial cured 94% of CDI patients.
-
Safe & Simple: Pasteurized, spray-dried egg powder (oral daily dose). Zero drugs or chemicals.
-
Prevention Protocol: 36-day course for at-risk seniors upon hospital entry.
Why Manitoba? A Win-Win Solution
Save Healthcare Dollars
Approximately 2,500 susceptible seniors (65+) enter Manitoba hospitals every month.
$1M/month prevention treatment cost vs $1.5M/month in avoided costs to treat infected patients (based on 75 preventable cases per month). This amounts to $500,000 savings to MB healthcare and taxpayers monthly.
Net savings projected within months, freeing up beds and resources.
Boost Local Economy
90,000 MB eggs/month sourced from Manitoba farmers → direct agricultural support.
This number raises to 22 million eggs per year to supply Canadian hospitals and the requirement of 7 new egg layer barns.
Jobs sustained and increased at our MB-based biotech facility.
Lead Medical Innovation
Position MB as a pioneer in preventive healthcare and AMR reduction.
Successful trial = global export potential to Canada and government-payer systems (UK, EU, Australia).
Prevent a Terrible Infection and Possible Death
C. Difficile infects and kills 500,000 and 30,000 people respectively in North America every year. The same mortality as Prostate Cancer.
The Proposal: A Low-Cost Short-Term Proof of Concept Trial
-
3-month pilot: Administer to 300 seniors/month entering MB hospital.
-
Cost to MB:$5M (fully covers doses, production, monitoring).
-
Success Metric: CDI case reduction vs. historical data—no placebo group needed.
-
Safety: Egg powder is food-grade with decades of safe use globally.
Why This is Low-Risk & High-Value
"Manitoba has a unique opportunity: leverage homegrown science and local resources to prevent a deadly infection, save millions in avoidable costs, and showcase our province as a leader in pragmatic healthcare innovation. Let’s turn our eggs into life-saving shields—and our farms into frontline healthcare partners."
Summary
1 Anchoring Savings
$1M/month cost with $1.5M+/month savings.
2 Local Pride
"Made in MB" eggs, jobs, and science.
3 Urgency
CDI’s 10% mortality in seniors.
4 Risk Mitigation
Patient-safe food product with nutritional benefits.
5 Bigger Vision
MB as a global proof-of-concept leader.
